ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

MGF

MGF

Also known as: Mechano Growth Factor, IGF-1Ec, MGF peptide

Overview

Key Facts

Primary Goal: Research and therapeutic applications of MGF

Unique E-domain peptide activates quiescent satellite (stem) cells in damaged muscle. Initiates satellite cell proliferation before they differentiate (priming phase).

Dosing Information

Half-Life

5-7 minutes (extremely short, rapidly degraded by proteases)

Typical Dose

100–400 mcg

Frequency

Immediately post-workout, bilaterally into trained muscle groups

Cycle Length

4-5 weeks

Administration Routes:
intramuscular

Benefits

  • Activates dormant satellite cells to initiate muscle repair
  • Promotes local muscle-specific hypertrophy at injection site
  • Complements the later-acting systemic IGF-1 isoforms
  • May enhance recovery from acute muscle injury
  • Does not significantly impact systemic IGF-1 or insulin levels

Side Effects

Injection site pain and inflammationmild
Very short half-life limits practical utility of non-PEGylated formmild
Limited human safety datamild
Localized swelling at injection sitemild

Mechanism of Action

1

Unique E-domain peptide activates quiescent satellite (stem) cells in damaged muscle

2

Initiates satellite cell proliferation before they differentiate (priming phase)

3

Acts in an autocrine/paracrine manner within mechanically stressed muscle tissue

4

Signals through the IGF-1 receptor but with distinct downstream signaling kinetics due to E-domain

Contraindications

Do not use this peptide if any of the following apply:

  • Active malignancy
  • Pregnancy or breastfeeding
  • Acute muscle tears (may worsen inflammation acutely)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

MGF was discovered by Dr. Geoffrey Goldspink's group at University College London. Research demonstrated that mechanical overload induces MGF expression as the initial IGF-1 splice variant before shifting to IGF-1Ea (systemic). Animal studies show MGF administration increases muscle mass by 20% within weeks. The extremely short half-life of the synthetic peptide limits practical use, leading to the development of PEG-MGF for extended activity.

Frequently Asked Questions

Common questions about MGF

UK-Specific Information

Exclusive data points and guidance for UK residents using MGF

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok